Literature DB >> 10871324

Mechanisms of N-methyl-D-aspartate-induced apoptosis in phencyclidine-treated cultured forebrain neurons.

C Wang1, J A Kaufmann, M G Sanchez-Ross, K M Johnson.   

Abstract

Chronic administration of phencyclidine (PCP) to rats has been demonstrated to produce a sensitized locomotor response to PCP challenge that is associated with apoptotic cell death and an up-regulation of the N-methyl-D-aspartate (NMDA) receptor. To determine the underlying mechanisms, dissociated forebrain cultures were treated for 2 days with 3 microM PCP. After washout of PCP, NMDA was added (in the presence of Mg(2+)) for 20 h. The uptake of a vital dye and the release of lactate dehydrogenase measured cell viability. Apoptosis was assessed by an enzyme-linked immunosorbent assay that was specific for fragmented (histone-associated) DNA and an in situ assay for nicked DNA, terminal dUTP nick-end labeling. These assays showed that the effect of a nontoxic concentration of NMDA (30 microM) became lethal to approximately one-third of the neurons after chronic (48-h) PCP treatment. This treatment also resulted in a 47% increase in NR1 subunit mRNA, suggesting that NMDA-induced neuronal cell death after chronic PCP is due to NMDA receptor up-regulation. Furthermore, exposure of PCP-treated cultures to NMDA led to increased expression of Bax and decreased expression of Bcl-X(L). The Bcl-X(L)/Bax ratio was markedly decreased by 30 microM NMDA in the PCP-treated, but not control, cultures. Addition of superoxide dismutase and catalase prevented the decrease in Bcl-X(L)/Bax. This study suggests that NMDA-induced changes in Bax and/or Bcl-X(L) involve the formation of reactive oxygen species. By extrapolation, these data suggest that PCP-induced apoptosis in vivo may involve similar mechanisms and that cultured neurons may be a suitable model for the mechanistic study PCP toxicity in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871324

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  26 in total

1.  Protective function of nicotinamide against ketamine-induced apoptotic neurodegeneration in the infant rat brain.

Authors:  Najeeb Ullah; Ikram Ullah; Hae Young Lee; Muhammad Imran Naseer; Park Moon Seok; Jawad Ahmed; Myeong Ok Kim
Journal:  J Mol Neurosci       Date:  2011-12-08       Impact factor: 3.444

2.  The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2007-08-08       Impact factor: 3.996

Review 3.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

Review 4.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

Review 5.  How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.

Authors:  Xin Wang; António Pinto-Duarte; Terrence J Sejnowski; M Margarita Behrens
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

6.  NMDA receptors promote survival in somatosensory relay nuclei by inhibiting Bax-dependent developmental cell death.

Authors:  Juan Carlos de Rivero Vaccari; Gregory P Casey; Salman Aleem; Won-Mee Park; Roderick A Corriveau
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

7.  Gene expression profiling in the developing rat brain exposed to ketamine.

Authors:  Q Shi; L Guo; T A Patterson; S Dial; Q Li; N Sadovova; X Zhang; J P Hanig; M G Paule; W Slikker; C Wang
Journal:  Neuroscience       Date:  2010-01-18       Impact factor: 3.590

8.  Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture.

Authors:  Fang Liu; Tucker A Patterson; Natalya Sadovova; Xuan Zhang; Shuliang Liu; Xiaoju Zou; Joseph P Hanig; Merle G Paule; William Slikker; Cheng Wang
Journal:  Toxicol Sci       Date:  2012-10-11       Impact factor: 4.849

9.  BCL2L1 (BCL-X) promotes survival of adult and developing retinal ganglion cells.

Authors:  Jeffrey M Harder; Qian Ding; Kimberly A Fernandes; Jonathan D Cherry; Lin Gan; Richard T Libby
Journal:  Mol Cell Neurosci       Date:  2012-07-24       Impact factor: 4.314

Review 10.  Nitrative and oxidative stress in toxicology and disease.

Authors:  Ruth A Roberts; Debra L Laskin; Charles V Smith; Fredika M Robertson; Erin M G Allen; Jonathan A Doorn; William Slikker
Journal:  Toxicol Sci       Date:  2009-08-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.